Astrana Health, Inc. (ASTH) vs Establishment Labs Holdings Inc. (ESTA)

A side-by-side comparison of Astrana Health, Inc. and Establishment Labs Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASTH vs ESTA

growth of $100 · dividends reinvested · last 8y
ASTH +44.4% (+4.7%/yr)ESTA +168.6% (+13.1%/yr)ESTA compounded faster over this window
100200300400500Start $1002020202220242026$144$269
ASTH ESTA

ASTH vs ESTA: by the numbers

  • •ESTA is the larger company ($1.96B vs $1.83B market cap).
  • •ASTH is profitable (1.05% net margin) while ESTA runs a net loss (-15.82%).
  • •ASTH grew revenue faster over the past five years (53.77% vs 17.02% CAGR).

Metrics side by side

Valuation

MetricASTHESTA
P/E ratio45.03N/A
Forward P/E26.33N/A
P/S ratio0.477.96
P/B ratio2.2090.54
EV / EBITDA13.43N/A
FCF yield8.68%N/A

Profitability

MetricASTHESTA
Gross margin9.22%70.49%
Operating margin2.61%-18.48%
Net margin1.05%-15.82%
ROE4.88%-179.99%
ROIC4.13%-6.53%

Growth (annualized)

MetricASTHESTA
Revenue CAGR (5Y)53.77%17.02%
EPS CAGR (5Y)-15.06%N/A
FCF CAGR (5Y)18.35%N/A
Total return CAGR (5Y)-16.52%-1.56%

Frequently asked

Which has grown faster, ASTH or ESTA?
Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus ESTA at 17.02%.
Is ASTH or ESTA more profitable?
ASTH runs the higher net margin — ASTH at 1.05% versus ESTA at -15.82%.
How have ASTH and ESTA total returns compared?
Over the past 5 years, ASTH delivered -16.52% and ESTA delivered -1.56% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.